𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's disease

✍ Scribed by S. P. Close; P. J. Elliott; A. G. Hayes; A. S. Marriott


Publisher
Springer
Year
1990
Tongue
English
Weight
622 KB
Volume
102
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Neuroprotective effects of (±)-kavain in
✍ Nicole Schmidt; Boris Ferger 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 2 views

This is the first study to investigate the potential protective effects of the lipophilic kavapyrone (+/-)-kavain in the experimental MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of Parkinson's disease (PD). Male C57BL/6 mice were treated with (+/-)-kavain (50, 100, or 200 mg/kg i.p.) o

Topiramate reduces levodopa-induced dysk
✍ Monty A. Silverdale; S.L. Nicholson; A.R. Crossman; J.M. Brotchie 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Abstract Overactive AMPA receptor‐mediated transmission may be involved in the pathogenesis of levodopa‐induced dyskinesia. The mechanism of action of the anticonvulsant drug topiramate involves attenuation of AMPA receptor‐mediated transmission. In this study, the potential antidyskinetic actio

Effect of histamine H2 receptor antagoni
✍ Tom H. Johnston; Anne van der Meij; Jonathan M. Brotchie; Susan H. Fox 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 823 KB

## Abstract Levodopa‐induced motor complications, including dyskinesia and wearing off, are troublesome side effects of treatment and impair quality of life in Parkinson's disease (PD) patients. The use of nondopaminergic agents as adjuncts to levodopa are potential options for managing these probl